![logo of the EU drugs agency](/userfiles/image/logos/main-site-logo.gif)
You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Part (iii) Estimated trends of injecting drug use
Country | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | Drug use | Method |
---|
Cyprus | | | | 1.08 | 1.05 | 1.13 | IDU | TP |
Czech Republic | | | | 3.73 | 4.1 | | IDU | TM |
Greece | | | 1.29 | 1.4 | 1.26 | 1.3 | IDU | CR |
UK | 3.2 | | | 4.18 | 3.95 | | IDU | OT |
Norway | 4.8 | 4.05 | 3.45 | 3.25 | 3.18 | | IDU | MM |
Notes:
Time-series are combined where methods are similar over the time span. In some countries data are insufficient to report. |
Target groups may vary between countries owing to different methods and data sources; therefore comparisons should be made with caution. | Related links:
SB2006: Figure PDU-5 |
For more details see Tables PDU-1, PDU-102 and PDU-103 in the Statistical bulletin 2008. |
See also ‘General notes for interpreting data’ on the Explanatory notes and help page |
See also EMCDDA project (2003): National prevalence estimates of problem drug use in the European Union, 1995–2000, CT.00.RTX.23, EMCDDA, Lisbon, coordinated by the Institut für Therapieforschung, Munich. | Sources:
Reitox national focal points |
(see the help page for information about formats etc.)